Prostate-specific antigen (PSA) as a surrogate end point for survival in prostate cancer clinical trials.
Collette
Laurence
L
D014408:Biomarkers, Tumor / Q000097:blood; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy / Q000379:methods; D018572:Disease-Free Survival; D006801:Humans; D008297:Male; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000401:mortality / Q000628:therapy; D015996:Survival Rate
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen